Artra Group Corporation AI Stock Analysis
Want to see JP:6029 full AI Analyst Report?
Artra Group Corporation (6029) AI Stock Analysis
Artra Group Corporation
(TSE/TYO:6029)
The company's strong financial turnaround, marked by improved profitability, cash flow, and a healthy balance sheet, is the most significant positive factor. However, the score is constrained by a persistent decline in revenue and weak technical momentum, with the stock trading below key short-term averages. The moderate valuation partially offsets these concerns, but the lack of a dividend and clear growth catalysts limits upside potential.
Artra Group Corporation (6029) vs. iShares MSCI Japan ETF (EWJ)
- Market Cap
- JPY 1.88B
- Dividend Yield
- ―
- Average Volume (3M)
- 103.06K
- Price to Earnings (P/E)
- 9.1
- Beta (1Y)
- 1.17
- Revenue Growth
- -11.43%
- EPS Growth
- -11.24%
- Country
- Japan
- Employees
- 131
- Sector
- Healthcare
- Sector Strength
- 51
- Industry
- Medical - Care Facilities
Artra Group Corporation Business Overview & Revenue Model
Company Description
Artra Group Corporation delivers diverse support services to acupuncture and osteopathic clinics across Japan. Its offerings encompass billing solutions and HONEY-STYLE, a specialized platform facilitating word-of-mouth marketing and reservation mana...
Artra Group Corporation Financial Statement Overview
Summary
Financial health is solid, driven by strong margin expansion, positive net income, and a significantly deleveraged balance sheet. Robust free cash flow generation supports stability. The primary offset is a persistent multi-year revenue decline, which tempers the overall score.
Income Statement
70PositiveBalance Sheet
85Very PositiveCash Flow
75Positive| Breakdown | TTM | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 3.66B | 3.93B | 4.23B | 4.50B | 4.67B | 3.16B |
| Gross Profit | 1.28B | 1.35B | 1.33B | 1.46B | 1.57B | 876.25M |
| EBITDA | 295.24M | 360.55M | 146.84M | 228.12M | 190.55M | -163.55M |
| Net Income | 96.77M | 258.29M | -36.74M | 53.00M | 2.10M | -351.12M |
Balance Sheet | ||||||
| Total Assets | 3.40B | 4.13B | 4.11B | 4.57B | 4.65B | 5.60B |
| Cash, Cash Equivalents and Short-Term Investments | 1.18B | 1.13B | 1.05B | 1.14B | 1.23B | 1.84B |
| Total Debt | 742.97M | 1.05B | 1.29B | 1.54B | 1.91B | 2.44B |
| Total Liabilities | 1.74B | 2.43B | 2.68B | 3.13B | 3.35B | 4.16B |
| Stockholders Equity | 1.66B | 1.70B | 1.44B | 1.45B | 1.31B | 1.44B |
Cash Flow | ||||||
| Free Cash Flow | 0 | 246.64M | 122.36M | 142.00M | -288.93M | -264.76M |
| Operating Cash Flow | 0 | 287.21M | 200.85M | 217.00M | -132.55M | -208.56M |
| Investing Cash Flow | 0 | 24.68M | -31.16M | -11.00M | -154.17M | -563.84M |
| Financing Cash Flow | 0 | -233.24M | -259.74M | -300.00M | -314.62M | 895.50M |
Artra Group Corporation Technical Analysis
Price Trends
Market Momentum
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For JP:6029, the sentiment is Negative. The current price of 175.00 is below the 20-day moving average (MA) of 181.10, below the 50-day MA of 185.56, and below the 200-day MA of 179.51, indicating a bearish trend. The MACD of -3.42 indicates Positive momentum. The RSI at 46.64 is Neutral, neither overbought nor oversold. The STOCH value of 61.32 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for JP:6029.
Artra Group Corporation Peers Comparison
Overall Rating
JP:922079Outperform
JP:921470Outperform
JP:602969Neutral
JP:237357Neutral
JP:242555Neutral
JP:736252Neutral
Financial Indicators
| Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
| 79Outperform | JPY 3.08B | 6.39 | ― | 3.40% | 5.71% | 10.34% | |
| 70Outperform | JPY 1.91B | 13.21 | ― | ― | 27.36% | 22.17% | |
| 69Neutral | JPY 1.90B | 9.08 | ― | ― | -11.43% | -11.24% | |
| 57Neutral | JPY 5.21B | 18.02 | ― | 4.46% | 4.76% | -52.55% | |
| 55Neutral | JPY 2.50B | 28.45 | ― | 3.34% | -3.64% | -66.52% | |
| 52Neutral | JPY 1.31B | 8.14 | ― | ― | 20.92% | 135.80% | |
| Sector * | 51Neutral | $7.86B | -0.30 | -43.30% | 2.27% | 22.53% | -2.21% |
* Healthcare Sector Average
Performance Comparison
| Show on chart | Ticker | Company Name | Price | Change | % Change |
|---|---|---|---|---|---|
| JP:6029 | Artra Group Corporation | 175.00 | 14.00 | 8.70% | |
| JP:2373 | Care Twentyone Corporation | 381.00 | -47.26 | -11.04% | |
| JP:2425 | Care Service Co., Ltd. | 659.00 | -103.11 | -13.53% | |
| JP:7362 | Terminalcare Support Institute, Inc. | 856.00 | 35.04 | 4.27% | |
| JP:9214 | Recovery International Co.,Ltd. | 1350.00 | -70.00 | -4.93% | |
| JP:9220 | FB CARE SERVICE CO.,LTD. | 1265.00 | 79.62 | 6.72% |
Disclaimer
This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.
Date of analysis: Nov 05, 2026
